Concerta and Peppermint drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Concerta (methylphenidate hydrochloride) and Peppermint (peppermint). Common drug interactions include blood pressure increased among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Concerta and Peppermint. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Concerta?

Concerta has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 25,040 Concerta users. Check the latest studies of Concerta.

What is Peppermint?

Peppermint has active ingredients of peppermint. eHealthMe is studying from 1,327 Peppermint users. Check the latest studies of Peppermint.

On Jul, 18, 2026

14 people who take Concerta and Peppermint together, and have interactions are studied.

Concerta and Peppermint drug interactions.

What are the common drug interactions of Concerta and Peppermint, by gender? *:

female:

Blood pressure increased
Alopecia (absence of hair from areas of the body)
Application site erythema (redness of the skin at application site)
Circadian rhythm sleep disorder (family of sleep disorders affecting, among other things, the timing of sleep)
Ear infection
Fatigue (feeling of tiredness)
Headache (pain in head)
Hypotension (abnormally low blood pressure)
Labyrinthitis (inflammation of the labyrinth or inner ear)
Nausea (feeling of having an urge to vomit)

male:

Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Concerta and Peppermint, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Dyspnoea (difficult or laboured respiration)
Hypotension (abnormally low blood pressure)
Labyrinthitis (inflammation of the labyrinth or inner ear)
Tympanic membrane perforation (a break in continuity of ear drum)

30-39:

Administration site pain
Application site erythema (redness of the skin at application site)
Ear infection
Sinusitis (inflammation of sinus)
Skin infection

40-49:

n/a

50-59:

Alopecia (absence of hair from areas of the body)
Blood pressure increased
Circadian rhythm sleep disorder (family of sleep disorders affecting, among other things, the timing of sleep)
Dizziness
Fluid retention (an abnormal accumulation of fluid in the blood)
Joint swelling
Oedema (fluid collection in tissue)
Peripheral swelling
Renal cyst (kidney cyst)
Tinnitus (a ringing in the ears)

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 35.71%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 35.71%
Immunodeficiency Common Variable: 4 people, 28.57%
Dry Skin: 4 people, 28.57%
Athlete's Foot (a fungal infection affecting the skin between the toes): 4 people, 28.57%
Drowsiness: 2 people, 14.29%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.14%
Headache (pain in head): 1 person, 7.14%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Concerta and Peppermint?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously